| 摘要 |
<p>The invention provides a composition which comprises cold-shocked M. vaccae or cold-shock proteins from M. vaccae together with a pharmaceutically acceptable carrier or diluent. Compositions of the invention are used for a method of treatment of the human or animal body, particularly conditions associated with exposure to cold including Raynaud's phenomenon, Raynaud's disease, hypothermia and frostbite.</p> |
